CD40-CD40 Ligand Mediates the Recruitment of Leukocytes and Platelets in the Inflamed Murine Colon

Gastroenterology

Volumn 132, Issue 3, 2007, Pages 955-965

  Vowinkel, Thorsten ^a,b   Anthoni, Christoph ^a,b   Wood, Katherine C ^a   Stokes, Karen Y ^a   Russell, Janice ^a   Gray, Laura ^a   Bharwani, Sulaiman ^a   Senninger, Norbert ^b   Alexander, J Steven ^a   Krieglstein, Christian F ^b   Grisham, Matthew B ^a   Granger, D Neil ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; DEXTRAN SULFATE; DRINKING WATER; MYELOPEROXIDASE; TRAPIDIL;

ANIMAL TISSUE; ARTICLE; ATTENUATION; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; ENDOSCOPY; ENTERITIS; GENE EXPRESSION; HISTOLOGY; ISOTOPE LABELING; LEUKOCYTE; MICROVASCULATURE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE; TISSUE INJURY; WILD TYPE;

EID: 33947314966     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.12.027     Document Type: Article

References (46)

1. Vowinkel T., Wood K.C., Stokes K.Y., Russell J., Krieglstein C.F., and Granger D.N. Differential expression and regulation of murine CD40 in regional vascular beds. Am J Physiol Heart Circ Physiol 290 (2006) H631-H639
2. Danese S., de la Motte C., Sturm A., Vogel J.D., West G.A., Strong S.A., Katz J.A., and Fiocchi C. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 124 (2003) 1249-1264
3. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., and Kroczek R.A. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391 (1998) 591-594
4. Danese S., de la Motte C., Reyes B.M., Sans M., Levine A.D., and Fiocchi C. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol 172 (2004) 2011-2015
5. Ishikawa M., Vowinkel T., Stokes K.Y., Arumugam T.V., Yilmaz G., Nanda A., and Granger D.N. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation 111 (2005) 1690-1696
6. Ludwiczek O., Kaser A., and Tilg H. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases. Int J Colorectal Dis 18 (2003) 142-147
7. Koutroubakis I.E., Theodoropoulou A., Xidakis C., Sfiridaki A., Notas G., Kolios G., and Kouroumalis E.A. Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease. Eur J Gastroenterol Hepatol 16 (2004) 1147-1152
8. Liu Z., Colpaert S., D'Haens G.R., Kasran A., de Boer M., Rutgeerts P., Geboes K., and Ceuppens J.L. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol 163 (1999) 4049-4057
9. Polese L., Angriman I., Cecchetto A., Norberto L., Scarpa M., Ruffolo C., Barollo M., Sommariva A., and D'Amico D.F. The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation. Eur J Gastroenterol Hepatol 14 (2002) 237-241
10. Clegg C.H., Rulffes J.T., Haugen H.S., Hoggatt I.H., Aruffo A., Durham S.K., Farr A.G., and Hollenbaugh D. Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice. Int Immunol 9 (1997) 1111-1122
11. Stuber E., Strober W., and Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 183 (1996) 693-698
12. Liu Z., Geboes K., Colpaert S., Overbergh L., Mathieu C., Heremans H., de Boer M., Boon L., D'Haens G., Rutgeerts P., and Ceuppens J.L. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions. J Immunol 164 (2000) 6005-6014
13. De Jong Y.P., Comiskey M., Kalled S.L., Mizoguchi E., Flavell R.A., Bhan A.K., and Terhorst C. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration. Gastroenterology 119 (2000) 715-723
14. Danese S., Scaldaferri F., Papa A., Pola R., Gasbarrini A., Sgambato A., and Cittadini A. CD40L-positive platelets induce CD40L expression de novo in endothelial cells: adding a loop to microvascular inflammation. Arterioscler Thromb Vasc Biol 24 (2004) e162
15. Slupsky J.R., Kalbas M., Willuweit A., Henn V., Kroczek R.A., and Muller-Berghaus G. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 80 (1998) 1008-1014
16. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., and Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98 (1990) 694-702
17. Vowinkel T., Kalogeris T.J., Mori M., Krieglstein C.F., and Granger D.N. Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig Dis Sci 49 (2004) 556-564
18. Ostanin D.V., Pavlick K.P., Bharwani S., D'Souza D., Furr K.L., Brown C.M., and Grisham M.B. T cell-induced inflammation of the small and large intestine in immunodeficient mice. Am J Physiol Gastrointest Liver Physiol 290 (2006) G109-G119
19. Kawachi S., Morise Z., Jennings S.R., Conner E., Cockrell A., Laroux F.S., Chervenak R.P., Wolcott M., van der Heyde H., Gray L., Feng L., Granger D.N., Specian R.A., and Grisham M.B. Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T cells. Inflamm Bowel Dis 6 (2000) 171-180
20. Cooper H.S., Murthy S.N., Shah R.S., and Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69 (1993) 238-249
21. Ebaugh Jr. F.G., and Beeken W.L. Quantitative measurement of gastrointestinal blood loss. II. Determination of 24-hour fecal blood loss by a chemical photospectrometric technique. J Lab Clin Med 53 (1959) 777-788
22. Dieleman L.A., Palmen M.J., Akol H., Bloemena E., Pena A.S., Meuwissen S.G., and Van Rees E.P. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114 (1998) 385-391
23. Arndt H., Kubes P., Grisham M.B., Gonzalez E., and Granger D.N. Granulocyte turnover in the feline intestine. Inflammation 16 (1992) 549-559
24. Krawisz J.E., Sharon P., and Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87 (1984) 1344-1350
25. Cooper D., Chitman K.D., Williams M.C., and Granger D.N. Time-dependent platelet-vessel wall interactions induced by intestinal ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 284 (2003) G1027-G1033
26. Massberg S., Eisenmenger S., Enders G., Krombach F., and Messmer K. Quantitative analysis of small intestinal microcirculation in the mouse. Res Exp Med (Berl) 198 (1998) 23-35
27. Eppihimer M.J., Wolitzky B., Anderson D.C., Labow M.A., and Granger D.N. Heterogeneity of expression of E- and P-selectins in vivo. Circ Res 79 (1996) 560-569
28. Fraker P.J., and Speck Jr. J.C. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 80 (1978) 849-857
29. Henninger D.D., Panes J., Eppihimer M., Russell J., Gerritsen M., Anderson D.C., and Granger D.N. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 158 (1997) 1825-1832
30. Gelbmann C.M., Leeb S.N., Vogl D., Maendel M., Herfarth H., Scholmerich J., Falk W., and Rogler G. Inducible CD40 expression mediates NFkappaB activation and cytokine secretion in human colonic fibroblasts. Gut 52 (2003) 1448-1456
31. Vogel J.D., West G.A., Danese S., De La Motte C., Phillips M.H., Strong S.A., Willis J., and Fiocchi C. CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. Gastroenterology 126 (2004) 63-80
32. Henn V., Steinbach S., Buchner K., Presek P., and Kroczek R.A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98 (2001) 1047-1054
33. Collins C.E., Rampton D.S., Rogers J., and Williams N.S. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 9 (1997) 1213-1217
34. Wakefield A.J., Sawyerr A.M., Dhillon A.P., Pittilo R.M., Rowles P.M., Lewis A.A., and Pounder R.E. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 2 (1989) 1057-1062
35. Chakrabarti S., Varghese S., Vitseva O., Tanriverdi K., and Freedman J.E. CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler Thromb Vasc Biol 25 (2005) 2428-2434
36. Yang J., Hirata T., Croce K., Merrill-Skoloff G., Tchernychev B., Williams E., Flaumenhaft R., Furie B.C., and Furie B. Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration. J Exp Med 190 (1999) 1769-1782
37. Yang J., Furie B.C., and Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost 81 (1999) 1-7
38. Furie B., Furie B.C., and Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 86 (2001) 214-221
39. Granger D.N., Vowinkel T., and Petnehazy T. Modulation of the inflammatory response in cardiovascular disease. Hypertension 43 (2004) 924-931
40. Grewal I.S., and Flavell R.A. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16 (1998) 111-135
41. van Kooten C., and Banchereau J. CD40-CD40 ligand. J Leukoc Biol 67 (2000) 2-17
42. Zhou L., Ismaili J., Stordeur P., Thielemans K., Goldman M., and Pradier O. Inhibition of the CD40 pathway of monocyte activation by triazolopyrimidine. Clin Immunol 93 (1999) 232-238
43. Irving P.M., Pasi K.J., and Rampton D.S. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 3 (2005) 617-628
44. Mori M., Salter J.W., Vowinkel T., Krieglstein C.F., Stokes K.Y., and Granger D.N. Molecular determinants of the prothrombogenic phenotype assumed by inflamed colonic venules. Am J Physiol Gastrointest Liver Physiol 288 (2005) G920-G926
45. Collins C.E., Cahill M.R., Newland A.C., and Rampton D.S. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 106 (1994) 840-845
46. Collins C.E., and Rampton D.S. Platelet dysfunction: a new dimension in inflammatory bowel disease. Gut 36 (1995) 5-8